Skin Topoproteome under Adalimumab (Humira) Treatment in Patients with Moderate to Severe Psoriasis

Trial Profile

Skin Topoproteome under Adalimumab (Humira) Treatment in Patients with Moderate to Severe Psoriasis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2011

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Plaque psoriasis
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms TOTAL
  • Most Recent Events

    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top